Leaflet TRAVOPROST/TIMOLOL MYLAN 40mcg / 5mg / ml ophthalmic drops solution
Indicated for: glaucoma; ocular hypertension
Route of administration: ophthalmic
Substance: travoprost + timolol (glaucoma agent + beta blocker)
ATC: S01ED51 (Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents)
This medicine may cause dizziness or vertigo.
May lower blood pressure and increase the risk of falls.
Older people may have an increased risk of side effects.
Travoprost+timolol is a combination medication used in the treatment of open-angle glaucoma and ocular hypertension. Travoprost is a prostaglandin F2-alpha analog that reduces intraocular pressure by increasing the outflow of aqueous humor, while timolol is a beta-blocker that decreases aqueous humor production.
This combination is administered as eye drops, usually once daily in the evening. It is indicated for patients who do not respond adequately to monotherapy or require additional intraocular pressure reduction.
Common side effects include ocular irritation, conjunctival hyperemia, dry eyes, and a burning sensation. In rare cases, systemic adverse reactions such as bradycardia, hypotension, or respiratory difficulties may occur. It is important for patients to follow their doctor's instructions and avoid contact of the dropper tip with the eye or other surfaces.
Travoprost+timolol is an effective therapeutic option for managing elevated intraocular pressure, helping to prevent optic nerve damage and vision loss.
General data about TRAVOPROST/TIMOLOL MYLAN 40mcg / 5mg / ml
- Substance: travoprost + timolol
- Date of latest medicines list: 01-02-2018
- Product code: W64080001
- Concentration: 40mcg / 5mg / ml
- Pharmaceutical form: ophthalmic drops solution
- Quantity: 1
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.